Phase I study of TTC (Taxotere[docetaxel]/Temodar[temozolomide]/Cisplatin) in metastatic melanoma patients.

Trial Profile

Phase I study of TTC (Taxotere[docetaxel]/Temodar[temozolomide]/Cisplatin) in metastatic melanoma patients.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Jul 2012

At a glance

  • Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Temozolomide (Primary)
  • Indications Malignant melanoma
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Mar 2010 Actual end date (1 Nov 2007) added as reported by ClinicalTrials.gov.
    • 26 Mar 2010 Actual patient number (23) added as reported by ClinicalTrials.gov.
    • 26 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top